Nu Skin Enterprises, Inc. (NUS) stock
NUSNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/3070% below fair value
$3.87+0.09 (+2.38%)
Close on Nov 18, 2026Market cap $188.38MP/E –Yield –
Nu Skin Enterprises free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Nu Skin Enterprises's free cash flow for the twelve months ending Sep 30, 2026 was -$26.26M, down 149.2% year over year. For fiscal 2025 it was $46.01M, down 34.4% from the year before. Over ten years it grew -16.1% a year on average. The highest annual figure on record is $345.07M in fiscal 2013.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $46.01M | -34.4% |
| FY2024 | Dec 31, 2024 | $70.16M | +16.6% |
| FY2023 | Dec 31, 2023 | $60.15M | +22.7% |
| FY2022 | Dec 31, 2022 | $49.01M | -32.8% |
| FY2021 | Dec 31, 2021 | $72.97M | -76.9% |
| FY2020 | Dec 31, 2020 | $315.32M | +181.9% |
| FY2019 | Dec 31, 2019 | $111.86M | -15.5% |
| FY2018 | Dec 31, 2018 | $132.37M | -45.4% |
| FY2017 | Dec 31, 2017 | $242.40M | +7.7% |
| FY2016 | Dec 31, 2016 | $225.04M | -15.2% |
| FY2015 | Dec 31, 2015 | $265.49M | – |
| FY2014 | Dec 31, 2014 | -$157.94M | -145.8% |
| FY2013 | Dec 31, 2013 | $345.07M | +61.0% |
| FY2012 | Dec 31, 2012 | $214.33M | +17.4% |
| FY2011 | Dec 31, 2011 | $182.51M | +36.1% |
| FY2010 | Dec 31, 2010 | $134.10M | +17.9% |
| FY2009 | Dec 31, 2009 | $113.73M | +30.3% |
| FY2008 | Dec 31, 2008 | $87.30M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$19.47M | -210.9% |
| Q2 FY2026 | Jun 30, 2026 | $4.99M | -86.1% |
| Q1 FY2026 | Mar 31, 2026 | -$17.63M | – |
| Q4 FY2025 | Dec 31, 2025 | $5.86M | -55.6% |
| Q3 FY2025 | Sep 30, 2025 | $17.57M | -23.1% |
| Q2 FY2025 | Jun 30, 2025 | $35.78M | -17.0% |
| Q1 FY2025 | Mar 31, 2025 | -$13.20M | – |
| Q4 FY2024 | Dec 31, 2024 | $13.20M | -60.9% |
| Q3 FY2024 | Sep 30, 2024 | $22.84M | -41.6% |
| Q2 FY2024 | Jun 30, 2024 | $43.08M | +107.0% |
| Q1 FY2024 | Mar 31, 2024 | -$8.96M | – |
| Q4 FY2023 | Dec 31, 2023 | $33.78M | +187.7% |
| Q3 FY2023 | Sep 30, 2023 | $39.12M | +1210.1% |
| Q2 FY2023 | Jun 30, 2023 | $20.81M | -43.8% |
| Q1 FY2023 | Mar 31, 2023 | -$33.56M | – |
| Q4 FY2022 | Dec 31, 2022 | $11.74M | -87.1% |
| Q3 FY2022 | Sep 30, 2022 | $2.99M | -82.1% |
| Q2 FY2022 | Jun 30, 2022 | $37.02M | +1042.8% |
| Q1 FY2022 | Mar 31, 2022 | -$2.74M | – |
| Q4 FY2021 | Dec 31, 2021 | $91.28M | +14.6% |
| Q3 FY2021 | Sep 30, 2021 | $16.68M | -83.0% |
| Q2 FY2021 | Jun 30, 2021 | $3.24M | -96.3% |
| Q1 FY2021 | Mar 31, 2021 | -$38.23M | -177.0% |
| Q4 FY2020 | Dec 31, 2020 | $79.68M | +117.6% |
| Q3 FY2020 | Sep 30, 2020 | $98.25M | +227.7% |
| Q2 FY2020 | Jun 30, 2020 | $87.75M | +30.6% |
| Q1 FY2020 | Mar 31, 2020 | $49.64M | – |
| Q4 FY2019 | Dec 31, 2019 | $36.62M | -39.8% |
| Q3 FY2019 | Sep 30, 2019 | $29.98M | -37.6% |
| Q2 FY2019 | Jun 30, 2019 | $67.21M | +80.3% |
| Q1 FY2019 | Mar 31, 2019 | -$21.95M | – |
| Q4 FY2018 | Dec 31, 2018 | $60.81M | -51.6% |
| Q3 FY2018 | Sep 30, 2018 | $48.05M | -20.7% |
| Q2 FY2018 | Jun 30, 2018 | $37.27M | -26.7% |
| Q1 FY2018 | Mar 31, 2018 | -$13.77M | -355.0% |
| Q4 FY2017 | Dec 31, 2017 | $125.56M | +68.2% |
| Q3 FY2017 | Sep 30, 2017 | $60.56M | – |
| Q2 FY2017 | Jun 30, 2017 | $50.88M | – |
| Q1 FY2017 | Mar 31, 2017 | $5.40M | – |
| Q4 FY2016 | Dec 31, 2016 | $74.63M | – |
See a number that looks wrong?